The accumulated evidence confirms that miRNAs may play a key role in the pathogenesis of pancreatic cancer, influencing important genetic changes such as KRAS, Tp53, and TGFβ/SMAD, and supporting the unfavorable tumor microenvironment. This evidence concerns the gene KRAS and familial pancreatic carcinoma.